Zhejiang Hisun Pharmaceutical Co Ltd (shse:600267) Share Price

Company Profile

Business description
Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.
Contact
No. 46 Waisha Road
Jiaojiang District
Zhejiang Province
Taizhou318000
CHN
T: +86 4001180618
http://www.hisunpharm.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
7,994

Recommended

Shares fall close to 18% after reporting higher marketing expenses.

Roy Van Keulen | 03 March 2026

Semiconductor companies Sandisk, Teradyne, and Applied Materials saw the largest fair value hikes.

Bella Albrecht | 03 March 2026

We think Berkshire Hathaway stock is fairly valued.

Greggory Warren, CFA | 03 March 2026

Index	Last price	Change	% Change
All Ordinaries	9,117.10	40.60	-0.44%
CAC 40	8,131.00	27.16	0.34%
DAX 40	23,919.11	128.46	0.54%
Dow JONES (US)	48,501.27	403.51	-0.83%
FTSE 100	10,498.35	14.22	0.14%
HKSE	25,249.48	518.60	-2.01%
NASDAQ	22,516.69	232.17	-1.02%
Nikkei 225	54,245.54	2,033.51	-3.61%
NZX 50 Index	13,531.12	89.09	-0.65%
S&P 500	6,816.63	64.99	-0.94%
S&P/ASX 200	8,901.20	35.80	-0.40%
SSE Composite Index	4,082.47	40.20	-0.98%